ROCKLAND, Mass.--(BUSINESS WIRE)--BioSphere Medical, Inc. (NASDAQ: BSMD) today announced a podium presentation and key abstracts related to the Company’s embolic products for the treatment of symptomatic uterine fibroids, liver cancer and arteriovenous malformations have been accepted at the Society for Interventional Radiologists (SIR) 32nd Annual Scientific Meeting being held March 1-6, 2007 in Seattle, Washington.
